THOROFARE, N.J., March 28, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (AKR.L) (Nasdaq:AKER), (the “Company” or “Akers”), a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the fiscal year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
